Vendor description
This vendor hasn't published their own description yet. It will appear here once they claim this profile and add it from their dashboard.
At a glance
- Brainomix (now part of Oxford Biomedica) provides AI-powered stroke imaging analysis,with applications in cerebrovascular clinical trial endpoints and patient…
- Coverage: Global · Phase II–IV
- Therapeutic focus: Neurology, Stroke
- Scale: Small,Medium
Company fit
Best suited for
Stroke and neurovascular trials requiring AI imaging assessment
Study fit
Best suited for stroke and neurovascular trials requiring ai imaging assessment.
Core strengths
- Stroke imaging AI
- University of Oxford spinout
- CE-marked
Considerations
- Stroke/neurology focus
- Not trial ops
Key facts
- Category
- AI / Machine Learning
- Geography
- Global
- Studies managed
- 12
- HQ
- United Kingdom
- Company size
- 100 employees
- Year founded
- 2013